You are here

Clinical Trials: Skin Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, October 8, 2021 - 12:00
Conditions:   Diabetic Foot;   Diabetic Foot Ulcer;   Amputation
Intervention:   Device: SEFFICARE
Sponsors:   Azienda Ospedaliero-Universitaria di Modena;   University of Modena and Reggio Emilia
Not yet recruiting
Posted: Monday, August 23, 2021 - 12:00
Condition:   Systemic Sclerosis
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Posted: Friday, August 13, 2021 - 12:00
Condition:   Dermatitis, Atopic
Interventions:   Biological: FURESTEM-AD® inj. 5.0 X 10^7 cells/1.5 mL;   Biological: Placebo
Sponsor:   Kang Stem Biotech Co., Ltd.
Posted: Monday, July 26, 2021 - 12:00
Conditions:   Polymyositis;   Dermatomyositis
Intervention:   Biological: PN-101
Sponsor:   Paean Biotechnology Inc.
Not yet recruiting
Posted: Wednesday, July 21, 2021 - 12:00
Condition:   Skin Ulcer Venous Stasis Chronic
Interventions:   Biological: allo-APZ2-CVU;   Drug: Placebo
Sponsors:   RHEACELL GmbH & Co. KG;   FGK Clinical Research GmbH;   Ticeba GmbH
Not yet recruiting
Posted: Tuesday, June 8, 2021 - 12:00
Conditions:   Systemic Sclerosis;   Inflammatory Myopathies
Intervention:   Other: Collection of biological samples
Sponsor:   University Hospital, Strasbourg, France
Not yet recruiting
Posted: Wednesday, May 12, 2021 - 12:00
Condition:   Androgenetic Alopecia
Intervention:   Device: Fractionated Thulium laser
Sponsor:   Montefiore Medical Center
Not yet recruiting
Posted: Tuesday, April 13, 2021 - 12:00
Condition:   Vitiligo
Intervention:   Other: The resident memory T-cell infiltrate in perilesional vitiligo skin
Sponsor:   Centre Hospitalier Universitaire de Nice
Not yet recruiting
Posted: Thursday, March 25, 2021 - 12:00
Condition:   Osteoarthritis, Knee
Interventions:   Drug: Fisetin;   Drug: Losartan;   Drug: Placebo - Losartan;   Drug: Placebo Fisetin
Sponsors:   Steadman Philippon Research Institute;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not yet recruiting
Posted: Friday, March 5, 2021 - 12:00
Conditions:   Traditional Chinese Medicine;   Drug Effect;   Drug Safety;   Psoriasis;   Mesenchymal Stromal Cells
Interventions:   Drug: PSORI-CM01 formula;   Drug: Gu Ben Hua Yu formula;   Biological: adipose-derived multipotent mesenchymal stem cells
Sponsor:   Guangdong Provincial Hospital of Traditional Chinese Medicine